Lewy body dementia is the second most common cause of neurodegenerative dementia in older people yet has received less focus than other subtypes of dementia. We want to change that and it starts with better research.
A new model for disease research is evolving: open, coordinated collaborations between academic researchers, pharmaceutical and biotech companies, private foundations and government agencies with patients, caregivers and patient advocacy groups as key collaborators
Our research strategy includes all aspects of Lewy body dementia, from lab bench to the bedside.
The Lewy body Society aims to:
Enhance the translation of research discoveries into better patient care.
Read more about our objectives for research , the process for deciding grants and our conflict of interest policy.
Along with all AMRC charity members, we support the principle of using animals in research when it is necessary to advance understanding of health and disease and to develop new treatments. This research only takes place where there is no alternative available.
